Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1991
10/31/1991CA2041454A1 Polypeptides
10/31/1991CA2041271A1 Peptide analogs to proteins of the immunoglobin superfamily
10/30/1991EP0454651A2 Novel platelet-aggregation inhibitors
10/30/1991EP0454400A2 Repopulation of macrophages and granulocytes using transforming growth factor-beta
10/30/1991EP0454383A1 Large intestinal dissociative polypeptide series oral formulation
10/30/1991EP0454372A1 Anticoagulant protein and method of production
10/30/1991EP0454367A2 Growth hormone releasing factor analogs
10/30/1991EP0454302A2 Tuftsin derivatives
10/30/1991EP0454084A1 Method of manufacturing iron-fortified beverage
10/30/1991EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
10/30/1991EP0454026A1 Pharmaceutical compositions containing epidermal growth factor for the treatment of neurodegenerative disorders
10/30/1991EP0453898A2 Use of TNF-specific antibodies as a drug for treatment of ischemias and of their consequences
10/30/1991EP0453561A1 Chimeric mouse human antibodies with specificity to hiv antigens
10/30/1991EP0453560A1 Localization and characterization of the wilms's tumor gene
10/30/1991EP0453554A1 Chimeric mouse human antibodies with specificity to hiv antigens
10/30/1991EP0453498A1 Method of promoting hair growth by applying a blood platelet extract
10/30/1991EP0453482A1 Biologically active synthetic thyrotropin and cloned gene for producing same
10/30/1991EP0438519A4 Therapeutic peptides
10/30/1991EP0333740B1 Pharmaceutically active conjugates having improved body tissue binding specificity
10/30/1991EP0305409B1 Solubilization of proteins for pharmaceutical compositions using polyproline conjugation
10/30/1991CA2041422A1 .alpha.-glycosyl naringin, and its preparation and uses
10/29/1991US5061806 Phosphinic acid derivatives
10/29/1991US5061787 Novel spergualin-related compounds and compositions
10/29/1991US5061786 Immunosuppressive agents
10/29/1991US5061729 Pharmaceutical composition and process for preparing the same
10/29/1991US5061722 Hypotensive agents; e.g. ramipril
10/29/1991US5061710 Mercapto-acylamino acid antihypertensives
10/29/1991US5061694 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
10/29/1991US5061693 Fibrinogen receptor antagonists
10/29/1991US5061692 Methods and compositions for the treatment of non-IgE-mediated diseases
10/29/1991US5061691 Analgesics
10/29/1991US5061690 Administering human growth regulating hormone during pregnancy
10/29/1991US5061689 Zinc bacitracin containing wound dressing
10/29/1991US5061688 Hemoglobin multiple emulsion
10/29/1991US5061622 Process for the production of κ-casein glycomacropeptide
10/29/1991US5061620 Capable of self-regeneration
10/29/1991US5061495 Antibiotic derived from b. subtilis
10/29/1991US5061492 biodegeadeable polymer matrix is copolymer of gylcolic acid a nd lactic acid
10/29/1991US5061489 Insecticidal bacillus thuringiensis strains with activity against lepidoptera
10/29/1991US5061488 Flavone-8-acetic acid and interleukin-2 for cancer therapy
10/29/1991CA1291592C Peptide antagonists of neurokinin b
10/28/1991WO1991017257A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME
10/28/1991WO1991016928A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
10/28/1991WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
10/28/1991WO1991016900A1 Fucosyl transferases involved in adhesion molecule expression
10/28/1991WO1991016819A1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein
10/28/1991CA2081479A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
10/28/1991CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
10/28/1991CA2079901A1 Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same
10/28/1991CA2063244A1 Fucosyl transferases involved in adhesion molecule expression
10/28/1991CA2042014A1 Method of treating or preventing baldness with compositions containing fibroblast growth factor
10/28/1991CA2041246A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
10/28/1991CA2041225A1 Galactosamine substitute of poly-w-substituted-l- glutamic acid (or aspartic acid)
10/25/1991WO1991016431A1 Soluble, truncated gamma-interferon receptors
10/25/1991CA2081309A1 Soluble, truncated gamma-interferon receptors
10/25/1991CA2040649A1 Growth hormone releasing factor analogs
10/24/1991WO1991016345A1 Cyclic peptides and their use
10/24/1991WO1991016067A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
10/24/1991DE4012319A1 Prodn. of lectin from Chondrilla nucula - has lymphocyte cyto-protective activity and is useful in treatment of e.g. AIDS or related diseases
10/24/1991CA2081312A1 Cyclic peptides and their use
10/24/1991CA2081023A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
10/24/1991CA2040965A1 Pharmaceutical compositions comprising tnf for induction of nerve regeneration
10/24/1991CA2040960A1 Anticoagulant protein and method of production
10/24/1991CA2040510A1 Composition and treatment with biologically active peptides and toxic cations
10/23/1991EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente
10/23/1991EP0453082A1 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
10/23/1991EP0452847A2 Use of a hypoallergenic wheat preparation for preparing a processed food for a person afflicted with food allergies to wheat
10/23/1991EP0452753A1 Essentially monomeric normal serum albumin (human)
10/23/1991EP0452598A1 Use of a polypeptide having interleukin-2 activity for the preparation of a pharmaceutical composition for the treatment of simple pleura cancer
10/23/1991EP0452505A1 M-csf derivative, expression vector of said derivative, product of transformation by said vector, and production of them
10/23/1991EP0452447A1 Reduced irreversible bombesin antagonists
10/23/1991EP0452433A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins
10/23/1991EP0452413A1 Generation and selection of novel dna-binding proteins and polypeptides
10/23/1991EP0452391A1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide.
10/23/1991EP0452364A1 Method for preparing water soluble polypeptides
10/23/1991EP0452315A1 Method of treating myeloid leukemias
10/23/1991EP0424470A4 Method for using protease inhibitors to treat and/or prevent pancreatitis
10/23/1991EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity
10/23/1991EP0170697B1 Toxin conjugates
10/23/1991CN1055560A Vectors and compounds for expression of glycosylation mutants of human protein c
10/23/1991CN1055541A Improved meninggococcal polysaccharide conjugate vaccine
10/23/1991CN1055540A 杂种降钙素 Hybrid calcitonin
10/23/1991CN1055483A Preparation of long active liposomes of peptide pharmaceutical and process for preparing them
10/22/1991US5059680 Method of isolating ca 125 antigen
10/22/1991US5059654 Affinity matrices of modified polysaccharide supports
10/22/1991US5059592 Composition for prevention and (or) treatment of AIDS
10/22/1991US5059589 Glaucoma treatment
10/22/1991US5059588 Methods and compositions for healing bone using gly his lys: copper
10/22/1991US5059586 Method for enhancing growth of mammary parenchyma
10/22/1991US5059537 Acellular vaccine
10/22/1991US5059530 Transforming escherichia coli with plasmid comprising structural gene, a promoter, a DNA fragment with tryptophan terminator, culturing, extracting and purifying
10/22/1991US5059529 Stabilized expression vectors containing λPL promoter and the gene for the cI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods
10/22/1991US5059528 Expression of human proapolipoprotein a-i
10/22/1991US5059425 For wound healing, implant acceptance; promote cellular attachment to culture substrate; inhibit metastatis of tumor cells
10/22/1991US5059419 Obtained by hyperimmunization of an equine
10/22/1991US5059418 Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
10/22/1991CA1291294C Cationic oligopeptides having microbicidal activity
10/22/1991CA1291054C Antitumor antibiotics (ll-e33288 complex)
10/22/1991CA1291036C Nasal administration of drugs
10/21/1991WO1991016448A1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus
1 ... 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 ... 3163